Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

Section 2 – Product/Company Update Remote Pharmacy announces continued nationwide availability of its compounded GLP-1 formulations, including semaglutide and tirzepatide-based treatments, for ...

Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with ...

Tirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.

The ingredient tirzepatide, available as Mounjaro, has long been hailed the 'King Kong' of slimming jabs and a breakthrough in the war on obesity.

Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...

Since the FDA considers tirzepatide “available,” stakeholders can no longer rely on the FDA’s shortage list exception to compound “essentially copies” of tirzepatide injections.

“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...

Each Mounjaro ® KwikPen ® contains four fixed doses of 0.6 mL, each dose taken once weekly. 2 It is available in six different dose strengths (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg), 3 ...

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their prescribed obesity medication, according to findings published in Obesity.

Researchers found that pairing tirzepatide with hormone therapy boosts weight loss success in postmenopausal women—up to 17% ...